Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics

被引:15
|
作者
Groshkova, Teodora [1 ,2 ]
Metrebian, Nicola [1 ]
Hallam, Christopher [1 ,3 ]
Charles, Vikki [1 ]
Martin, Anthea [1 ]
Forzisi, Luciana [1 ]
Lintzeris, Nicholas [1 ,4 ,5 ]
Strang, John [1 ,4 ]
机构
[1] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England
[2] EMCDDA, P-1249289 Lisbon, Portugal
[3] Int Drug Policy Consortium, London, England
[4] Kings Hlth Partners, Acad Hlth Sci Ctr, London, England
[5] Univ Sydney, Langton Ctr, Sydney, NSW 2006, Australia
关键词
supervised injectable opiate treatment; expectation; treatment satisfaction; DRUG-USERS; HEROIN; METHADONE;
D O I
10.1111/dar.12062
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction and AimsThe study investigates patients' pre-treatment expectations of, and post-treatment satisfaction with, supervised injectable opiate treatment delivered within UK's first such clinics within the Randomised Injectable Opiate Treatment Trial (RIOTT) (ISRCTN0133807). Design and MethodsData were collected from 127 chronic heroin addicts recruited to RIOTT and randomised to receive supervised injectable (heroin or methadone) treatment or optimised oral maintenance treatment at supervised injectable maintenance clinics in London, Darlington and Brighton. ResultsOf 127 RIOTT patients, 113 (89%) provided responses to structured enquiry about treatment expectations, and 94 (74%) subsequent responses about treatment satisfaction (at six months). Patients were hoping that injectable heroin treatment would: reduce substance misuse (81%); help achieve normality, routine and structure (16%); and increase education and work prospects (15%). At six months, an area of treatment satisfaction most commonly reported by all three trial groups was reduced substance misuse (supervised injectable heroin 59%, supervised injectable methadone 56%, optimised oral methadone 54%). Most found supervision acceptable, but some desired modifications were also identified. Discussion and ConclusionsPatients previously considered non-responsive to treatment appear to have similar treatment expectations and aspirations as other drug users in treatment. Supervised injectable opioid treatment patients consistently reported treatment satisfaction but also that more could be done to optimise aspects of current arrangement. This raised the challenging issue of the extent to which opinions of patients need to be taken into consideration in shaping future treatment provision. Future research may need to examine the extent of expectations fit' and the relationship between treatment sought and received. [Groshkova T, Metrebian N, Hallam C, Charles V, Martin A, Forzisi L, Lintzeris N, Strang J. Treatment expectations and satisfaction of treatment-refractory opioid dependent patients in Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug Alcohol Rev 2013;32:566-573]
引用
收藏
页码:566 / 573
页数:8
相关论文
共 6 条
  • [1] Methodology for the randomised injecting opioid treatment trial (RIOTT): Evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK
    Lintzeris N.
    Strang J.
    Metrebian N.
    Byford S.
    Hallam C.
    Lee S.
    Zador D.
    Harm Reduction Journal, 3 (1)
  • [2] Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)
    Metrebian, Nicola
    Groshkova, Teodora
    Hellier, Jennifer
    Charles, Vikki
    Martin, Anthea
    Forzisi, Luciana
    Lintzeris, Nicholas
    Zador, Deborah
    Williams, Hugh
    Carnwath, Tom
    Mayet, Soraya
    Strang, John
    ADDICTION, 2015, 110 (03) : 479 - 490
  • [3] After the randomised injectable opiate treatment trial: Post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication
    Bond, Alyson J.
    Reed, Kylie D.
    Beavan, Pete
    Strang, John
    DRUG AND ALCOHOL REVIEW, 2012, 31 (04) : 492 - 498
  • [4] Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial
    Reimer, Jens
    Verthein, Uwe
    Karow, Anne
    Schaefer, Ingo
    Naber, Dieter
    Haasen, Christian
    ADDICTION, 2011, 106 (09) : 1647 - 1655
  • [5] A Placebo-Controlled Trial of Dextromethorphan as an Adjunct in Opioid-Dependent Patients Undergoing Methadone Maintenance Treatment
    Lee, Sheng-Yu
    Chen, Shiou-Lan
    Chang, Yun-Hsuan
    Chu, Chun-Hsien
    Chen, Shih-Heng
    Chen, Po See
    Huang, San-Yuan
    Tzeng, Nian-Sheng
    Wang, Liang-Jen
    Lee, I. Hui
    Wang, Tzu-Yun
    Chen, Kao Chin
    Yang, Yen Kuang
    Hong, Jau-Shyong
    Lu, Ru-Band
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (07) : 1 - 8
  • [6] A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment
    Holland, Richard
    Matheson, Catriona
    Anthony, Geraldine
    Roberts, Kennedy
    Priyardarshi, Saket
    MacRae, Ann
    Whitelaw, Eddie
    Appavoo, Sivaram
    Bond, Christine
    DRUG AND ALCOHOL REVIEW, 2012, 31 (04) : 483 - 491